Jill Ann Howe's Net Worth
$20.8 Thousand
Who is Jill Ann Howe?
Jill Ann Howe does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIORA THERAPEUTICS, INC., and Lineage Cell Therapeutics, Inc..
SEC CIK
Jill Ann Howe's CIK is 0001892397
Past Insider Trading and Trends
2024 was Jill Ann Howe's most active year for acquiring shares with 4 total transactions. Jill Ann Howe's most active month to acquire stocks was the month of May. 2023 was Jill Ann Howe's most active year for disposing of shares, totalling 1 transactions. Jill Ann Howe's most active month to dispose stocks was the month of December. 2024 saw Jill Ann Howe paying a total of $9,345.00 for 685,500 shares, this is the most they've acquired in one year. In 2023 Jill Ann Howe cashed out on 19 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIORA THERAPEUTICS, INC. (BIOR) Snapshot price: $0.655
InvestorJill Ann Howe owns 31,916 units of Common Stock which is worth $20,904.98. Jill Ann Howe used to own units in Series X Preferred Stock but no longer holds any shares there. From 2021 to 2024 Jill Ann Howe acquired a total of 197,908 shares in BIORA THERAPEUTICS, INC., Jill also disposed a total of 19 shares of BIORA THERAPEUTICS, INC..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +64.38% | 12.5K |
—
|
—
| 31.92K |
Jun 5
| |||
Form 4
| +180.74% | 12.5K |
—
|
—
| 19.42K |
Jun 14
| |||
Form 4
| -100.00% | -19.00 |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +125.28% | 96.15K |
—
|
—
| 172.91K |
Jun 15
| |||
Form 4
|
∞
| 76.75K |
—
|
—
| 76.75K |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lineage Cell Therapeutics, Inc. (LCTX) Snapshot price: $0.8778
Chief Financial OfficerJill Ann Howe owns 10,500 units of Common Shares which is worth $9,216.90. From 2022 to 2024 Jill Ann Howe acquired a total of 10,500 shares in Lineage Cell Therapeutics, Inc. at a cost of $9,345.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10.5K |
$0.89 | $9,345.00 | 10.5K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||